Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long‐Term Outcome

The main objective of this phase I trial was to assess the feasibility and safety of microtransplanting human neural stem cell (hNSC) lines into the spinal cord of patients with amyotrophic lateral sclerosis (ALS). Eighteen patients with a definite diagnosis of ALS received microinjections of hNSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzini, Letizia, Gelati, Maurizio, Profico, Daniela Celeste, Sorarù, Gianni, Ferrari, Daniela, Copetti, Massimiliano, Muzi, Gianmarco, Ricciolini, Claudia, Carletti, Sandro, Giorgi, Cesare, Spera, Cristina, Frondizi, Domenico, Masiero, Stefano, Stecco, Alessandro, Cisari, Carlo, Bersano, Enrica, De Marchi, Fabiola, Sarnelli, Maria Francesca, Querin, Giorgia, Cantello, Roberto, Petruzzelli, Francesco, Maglione, Annamaria, Zalfa, Cristina, Binda, Elena, Visioli, Alberto, Trombetta, Domenico, Torres, Barbara, Bernardini, Laura, Gaiani, Alessandra, Massara, Maurilio, Paolucci, Silvia, Boulis, Nicholas M., Vescovi, Angelo L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Human Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708070/
https://www.ncbi.nlm.nih.gov/pubmed/31104357
http://dx.doi.org/10.1002/sctm.18-0154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708070/
https://www.ncbi.nlm.nih.gov/pubmed/31104357
http://dx.doi.org/10.1002/sctm.18-0154

Ejemplares similares